Group One Trading, L.P. Fsd Pharma Inc. Transaction History

Group One Trading, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$1.07 - $1.6 $19,637 - $29,364	18,353 New	18,353 $22,000
Q1 2023 May 12, 2023	BUY	$0.77 - $1.81 $6,052 - $14,228	7,861 Added 72.83%	18,655 $28,000
Q4 2022 Feb 09, 2023	SELL	$0.73 - $1.07 $511 - $749	-700 Reduced 6.09%	10,794 $8,000
Q3 2022 Nov 09, 2022	SELL	$0.78 - $1.02 $13,678 - $17,887	-17,537 Reduced 60.41%	11,494 $10,000
Q2 2022 Aug 11, 2022	BUY	$0.78 - $1.1 $5,239 - $7,388	6,717 Added 30.1%	29,031 $23,000

Q1 2022 May 12, 2022	SELL	$0.82 - $1.1 $3,186 - $4,274	-3,886 Reduced 14.83%	22,314 $19,000
Q4 2021 Feb 11, 2022	BUY	$0.96 - $1.63 $8,508 - $14,446	8,863 Added 51.12%	26,200 $27,000
Q3 2021 Nov 12, 2021	BUY	$1.45 - $1.84 $25,138 - $31,900	17,337 New	17,337 $27,000

Ticker HUGE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 38,218,100
Market Cap $5.35M
Description
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.